Evidence map›Paper›PMID 29464351›Full record

ReviewCurrent rheumatology reports2018

Vasculitis in Africa.

Eugene Genga, Omondi Oyoo, Adewale Adebajo

Open access · hybridAbstract readReview
In one paragraph

Review in Current rheumatology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Kawasaki disease in Kenya and review of the African literature.Pediatric rheumatology online journal · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Giant Cell Arteritis: Updates and Controversies.Frontiers in ophthalmology · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Vasculitides in HIV Infection.Current rheumatology reports · 2020
    Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Eugene GengaDepartment of Clinical Medicine and Therapeutics, School of Medicine, College of Health sciences, University of Nairobi, P O Box 30197-0100, Nairobi, Kenya.
Omondi OyooDepartment of Clinical Medicine and Therapeutics, School of Medicine, College of Health Sciences, University of Nairobi, P O Box 19676-00202, Nairobi, Kenya.
Adewale AdebajoFaculty of Medicine, Dentistry and Health, University of Sheffield, Beech Hill Road, Sheffield, UK. a.o.adebjo@sheffield.ac.uk.
University of Nairobi · KEUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewSystemic vasculitides are characterized by inflammation of blood vessel walls leading to a myriad of organ disorders depending on the size, site, and location of the affected blood vessel. The epidemiology of vasculitis in the developing world has been inadequately documented. The description of the vasculitides in Africa, both from hospital series as well as taking into consideration, previous epidemiological studies in the community, indicates that these conditions have been rare until relatively recently. In view of these past observations, this review of publications on the topic looks to shed light on the current state of vasculitis in Africa. RECENT

findingsTakayasu and Kawasaki appear to be the most commonly reported vasculitides in Africa. Most of the published reports are from North and South Africa. Furthermore, the contribution of vasculitis associated with infections, and in particular HIV, is significant. There are increasing numbers of publications reflecting a growing recognition of the vasculitides in Africa.

Indexed as

AfricaBehcet SyndromeHIV InfectionsHumansMucocutaneous Lymph Node SyndromeTakayasu ArteritisVasculitisAfricaVasculitidesVasculitis

Identifiers

PMID29464351
PMCPMC5820371
OpenAlexW2791448398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.